Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers

NCT01431937 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG: GSK2018682
DRUG: Placebo

Sponsor

GlaxoSmithKline